Xiansheng Pharmaceutical (02096) announced that on April 15, 2024, it cost approximately HK$15.23 million to repurchase 288...
According to the Zhitong Finance App, Xiansheng Pharmaceutical (02096) announced that on April 15, 2024, it spent approximately HK$15.23 million to repurchase 2.885 million shares.